Carrie D'Andrea
CIK 1977969 · View on SEC EDGAR ↗
First SEC filing: May 10, 2024 · Latest: May 10, 2024
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| April 14, 2025 | GRCE | A | 30,000 | — | — | 30,000 Direct | — | Acquired | (price as of 2026-08-21) |
| May 6, 2024 | GRCE | A | 19,740 | — | — | 19,740 Direct | — | Acquired | (price as of 2026-08-21) |
| May 6, 2024 | GRCE | A | 19,740 | — | — | 19,740 Direct | — | Acquired | (price as of 2026-08-21) |
| July 14, 2023 | GRCE | A | 42,000 | — | — | 42,000 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| April 14, 2025 | GRCE | Stock Option (Right to Buy) | Common Stock (30,000) | $2.08 | April 14, 2035 | 30,000 | Acquired |
| May 6, 2024 | GRCE | Stock Options (Right to Buy) | Class A Common Shares (19,740) | $2.96 | May 6, 2034 | 19,740 | Acquired |
| May 6, 2024 | GRCE | Stock Options (Right to Buy) | Class A Common Shares (19,740) | $2.96 | May 6, 2034 | 19,740 | Acquired |
| July 14, 2023 | GRCE | Stock Options (Right to Buy) | Class A Common Shares (42,000) | $2.64 | July 14, 2033 | 42,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
GRCE
President, Clinical Operations| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2026 | $310,000 | — | — | $52,150 | $93,000 | — | $10,500 | $465,650 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.